Not only were we surprised by the different regulatory mechanisms of ARAF with respect to the ERBB3-AKT signaling axis, but also by the observation that ARAF, previously classified more as an oncogene, acts as a tumor suppressor in a subset of lung cancers. This evidence concerns the gene AKT1 and lung carcinoma.